FierceBiotech FierceBiotech IT FiercePharma FierceMedicalDevices
FierceBiotech Research FierceVaccines FiercePharma Manufacturing FierceDrugDelivery

Related Tags >> Transgene   Roche
Syndicate content

TG4001 News

Most Popular TG4001 Story

Roche pulls out of Transgene vaccine pact

Roche has decided to exit its pact to develop and commercialize TG4001 (RG3484), a therapeutic vaccine to treat high grade cervical intraepithelial neoplasia lesions caused by human papillomavirus Read more...

Latest Headlines